Pharma

Healthcare

Eli Lilly Invests Weight-Loss Windfall in Next-Gen Cancer Treatment

Photo via Gado Images/Smith Collection/Gado/Sipa USA/Newscom

Kelonia is developing a next-gen blood cancer treatment that’ll reprogram T-cells to help patients’ immune systems fight cancer.

2 min read

Photo via Andre M. Chang/ZUMAPRESS/Newscom

Healthcare

Neurocrine Scoops Up Hunger-Drug Maker in Latest Multi-Billion-Dollar Pharma Deal

Soleno Therapeutics’s Vykat XR is the first drug to be approved for treating the insatiable hunger caused by Prader-Willi Syndrome.

1 min read
Photo via Anthony Behar/Sipa USA/Newscom

Healthcare

Merck Preps for End of Keytruda Exclusivity with $6.7B Deal for Leukemia Treatment

The key patent protections on Keytruda, Merck’s immunotherapy treatment that outsold all other prescription drugs last year, ends in 2028.

1 min read
Photo via imageBROKER/Jim West/Newscom

Energy

JPMorgan Warns of ‘National Security Risk’ from Aging Power Grid

The grid is already being tested by the massive demand for data centers to support the artificial intelligence boom.

2 min read

Healthcare

GLP-1 Race Heats Up with Positive Test Results for Next-Gen Eli Lilly Drug

Photo via Gado Images/Smith Collection/Gado/Sipa USA/Newscom

Approximately one in eight Americans are taking medications like Ozempic or Wegovy for weight loss, diabetes, heart disease and more.

2 min read

Healthcare

Bayer Resurrects Scrapped Blood-Thinning Drug as Breakthrough Stroke Treatment

Photo via imageBROKER/Joko/Newscom

The trial proved so successful that Bayer plans to reach out to regulators in preparation for submitting the drug candidate for approval.

2 min read

Healthcare

China’s Multibillion-Dollar US Pharma Pipeline Draws Scrutiny in Washington

Photo via Mu Yu / Xinhua News Agency/Newscom

China’s pharmaceutical sector, a minor player just years ago, has revved up into a global juggernaut faster than a Fuxing high speed train.

2 min read

Sign Up for The Daily Upside to Unlock This Article

Sharp news & analysis on finance, economics, and investing.